Jan Schnitzer on Using Subtractive Proteomics to Target Therapeutics | GenomeWeb

At A Glance:

Name: Jan Schnitzer

Position: Scientific director, Sidney Kimmel Cancer Center, since 1999.

Published paper in June 10 issue of Nature: “Subtractive Proteomic Mapping of the Endothelial Surface in Lung and Solid Tumors for Tissue-Specific Therapy.”

Background: Scientific founder and director, Vascular Genomics, 1995-2001.

Assistant/Associate professor of pathology, Harvard Medical School, 1994-98.

Assistant professor of medicine and pathology, University of California San Diego, 1990-93.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.